DMI Announces Patent Issuance for rHEALTH ONE

Today, the rHEALTH ONE received a patent issuance from the United States Patent and Trademark Office, highlighting the instrument’s unique biomedical design. The patent recognizes its compact form factor, innovative sample-loading mechanism for microvolumes, and low-power operation.

The rHEALTH ONE integrates a matchbox-sized cytometry module, microparticles, and microvolume sample handling, enabling a wide range of biomarker and cellular analyses. This patent issuance further strengthens DMI’s intellectual property portfolio, reinforcing the company’s leadership in advanced point-of-care diagnostic technology.